Clinical trial · Observational
Quality Of Life Outcomes Following Treatment for Esophageal Cancer
NCT00598117CI-TRIAL-00011137completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this study is to evaluate how treatment for esophageal cancer affects your quality of life. The findings of this study may help us understand how this disease and its treatment affect your lifestyle, diet, exercise, support system and overall quality of life. We hope this study will provide important information that can be used to develop programs to improve the quality of life of patients with esophageal cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Esophageal Cancer | Malignant Esophageal Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Questionnaires | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- 1
- description
- Group 1 (newly diagnosed patients) Initial assessment → first post op visit → 6 and 12 months post surgery
- interventionNames
- Behavioral: Questionnaires
- label
- 2
- description
- Group 2 (post-treatment patients) A one-time assessment will be conducted at least 18 months following treatment
- interventionNames
- Behavioral: Questionnaires
Primary outcomes (1)
- measure
- To prospectively evaluate the quality of life of patients before and after esophageal cancer resection.
- timeFrame
- Initial assessment → first post op visit → 6 and 12 months post surgery
Secondary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Age 18 or older * Diagnosis of esophageal cancer. * Anticipated to undergo surgical resection (Ivor Lewis, Trans Hiatal, McKeown procedure) of esophageal cancer. (Group 1 patients only) * Underwent esophagectomy for esophageal cancer at least 18 months prior to consent, with no evidence of disease. (Group 2 patients only) * Ability to speak, read and write English. Exclusion Criteria: * Inability to give informed consent. * Patients anticipated to require a laryngectomy as part of their surgical resection.
References
Publications (0)
Data not yet available
No reference posted for this study.